Company Overview and News

19
Oh, You Really Think IBM Wasn't Dead Money?

2018-10-17 seekingalpha
After 22 straight quarters of declining revenue, IBM put an end to this sad streak and gave investors hope.
GLW GEC GE GNE PII

 
Polaris Industries (PII) Q3 Earnings Preview: What to Know Ahead of the Release

2018-10-15 zacks
Polaris Industries (PII - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2018. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
PII

2
WSI Industries Reports Preliminary Fourth Quarter and Fiscal Year 2018 Results; Declares Quarterly Dividend and Provides Update On Special Meeting

2018-10-04 globenewswire
MINNEAPOLIS, Oct. 04, 2018 (GLOBE NEWSWIRE) -- WSI Industries, Inc. (Nasdaq: WSCI) announced today its preliminary financial results for the fourth quarter and fiscal year 2018 ended August 26, 2018, which remain subject to customary annual audit procedures. Fiscal year 2018 annual sales were $34,604,000 versus the prior year’s sales of $30,641,000. The Company reported fiscal year 2018 net income of $847,000, or $0.
WSCI PII

2
Carnival's (CCL) Q3 Earnings: Ticket Revenues Holds the Baton

2018-09-21 zacks
Carnival Corporation (CCL - Free Report) is scheduled to report third quarter of fiscal 2018 results on Sep 27. In the last reported quarter, the company’s earnings surpassed the Zacks Consensus Estimate by 13.3%. Also, it has an average four-quarter positive earnings surprise of 16.1%.
CUKPF CCL RCL CCL UTX CUK PII EOG

4
Zacks Investment Ideas feature highlights: Apple, Alibaba and Polaris Industries

2018-09-19 zacks
Chicago, IL – September 19, 2018 – Today, Zacks Investment Ideas feature highlights Features: Apple (AAPL - Free Report) ), Alibaba (BABA - Free Report) ) and Polaris Industries (PII - Free Report) .
RYAM ESE GTS AAPL PII ON CVTI INT UNFI TSC

1
The Trade War Escalates, is China really out of Ammunition?

2018-09-18 zacks
In a widely anticipated move, the Trump administration announced on Monday afternoon that it would be imposing tariffs on an additional $200B worth of Chinese imports. The tariffs will go into effect on September 24th and will start at 10% and rise to 25% on January 1st, 2019, presumably to mitigate their impact on holiday shoppers in the U.S. who are purchasing Chinese imports.
TXN AAPL PII

8
Trump's Trade Policies: America's Brexit?

2018-09-10 seekingalpha
There is a risk that Trump's protectionist trade policies could do to the US, what Brexit may do to the UK.
GS NYTAB HOG PII

8
With A 21.9% Dividend Yield, REML Is Attractive

2018-08-23 seekingalpha
With an annualized yield of 21.9% on a monthly compounded basis, REML could be an attractive holding for those willing to accept the risks.
DGLD STAR ORC CS ABRN UGLD UBS AGNCP AGNC PII AGNCB ABR DSLV CEFL VIIX CSSLF VIIZ HOG CSGKF ARR ABRN.CL ZIV USLV TVIX ULSGF XIV

2
Midwest Spotlight: Twin Cities On the Move

2018-08-15 cnbc
Everyone dreams of living and working in a city that has it all: Robust job opportunities, affordable housing, access to great health care and schools, relatively affordable housing and an abundance of outdoor amenities, the list goes on.
AMP XEL GIS NYTAB PII

 
PII / Polaris Industries, Inc / VANGUARD GROUP INC - null (Passive Investment)

2018-08-08 sec.gov
polarisindustriesinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 <
PII

 
PII / Polaris Industries, Inc / VANGUARD GROUP INC - null (Passive Investment)

2018-08-08 sec.gov
polarisindustriesinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 <
PII

53
Factbox: Impact of U.S.-China trade tariffs on U.S. companies

2018-08-08 reuters - 2
(Reuters) - U.S. companies are putting in place measures to cushion the impact of escalating trade tensions between the United States and China.
MTSI FIT CAT NWL BSX HON BOE EGN GM PAA PII HON GEC GE CATR UTX HOME GNTX GNE BA DHR

14
Danaos Sees Hammer Chart Pattern: Time to Buy?

2018-08-01 zacks
Danaos Corporation (DAC - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because DAC recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
CBIO DAC PII

 
Polaris Industries (PII) Enters Oversold Territory

2018-08-01 zacks
Polaris Industries Inc. (PII - Free Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at PII given that, according to its RSI reading of 28.12, it is now in oversold territory.
DEI PII

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PII / Polaris Industries, Inc on message board site Silicon Investor.

TPII - Year 2000 (Y2K); Groupware; Client Server Migration TPII - Year 2000 (Y2K); Groupware; Client Server Migration TPII - Year 2000 (Y2K); Groupware; Client Server Migration IPII - Imperial Industries IPII - Imperial Industries IPII - Imperial Industries
DPII: Discovery Partners Intu0027l DPII: Discovery Partners Intu0027l DPII: Discovery Partners Intu0027l Peco II Inc. - PIII Peco II Inc. - PIII Peco II Inc. - PIII
EPII EPII EPII EPII - Eagle Pacific EPII - Eagle Pacific EPII - Eagle Pacific
RPII(RESEARCH PARTNERS INTENATIONAL) hot, brokerage sector RPII(RESEARCH PARTNERS INTENATIONAL) hot, brokerage sector RPII(RESEARCH PARTNERS INTENATIONAL) hot, brokerage sector TPII- year 2000 now TPII- year 2000 now TPII- year 2000 now
KPI International (KPII-Toronto), (KPIIF-NASDAQ) KPI International (KPII-Toronto), (KPIIF-NASDAQ) KPI International (KPII-Toronto), (KPIIF-NASDAQ) EPII, Great profits with little attention EPII, Great profits with little attention EPII, Great profits with little attention
CUSIP: 731068102